



@article {2184,
	title = {Regenerative medicine for the treatment of spinal cord injury: More than just promises?},
	journal = {Journal of Cellular and Molecular MedicineJ. Cell. Mol. Med.},
	volume = {16},
	year = {2012},
	note = {Export Date: 21 November 2012Source: Scopusdoi: 10.1111/j.1582-4934.2012.01603.xLanguage of Original Document: EnglishCorrespondence Address: P{\^e}go, A.P.; INEB - Instituto de Engenharia Biom{\'e}dica, Universidade do Porto, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal; email: apego@ineb.up.ptReferences: Fitch, M.T., Silver, J., CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure (2008) Exp Neurol, 209, pp. 294-301;Ronaghi, M., Erceg, S., Moreno-Manzano, V., Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? (2010) Stem Cells, 28, pp. 93-99; 
Wyndaele, M., Wyndaele, J.J., Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? (2006) Spinal Cord, 44, pp. 523-529; 
Willerth, S.M., Sakiyama-Elbert, S.E., Cell therapy for spinal cord regeneration (2008) Adv Drug Deliv Rev, 60, pp. 263-276; 
Hulsebosch, C.E., Recent advances in pathophysiology and treatment of spinal cord injury (2002) Adv Physiol Educ, 26, pp. 238-255; 
Fawcett, J.W., Overcoming inhibition in the damaged spinal cord (2006) J Neurotrauma, 23, pp. 371-383; 
Garcia-Alias, G., Lin, R., Akrimi, S.F., Therapeutic time window for the application of chondroitinase ABC after spinal cord injury (2008) Exp Neurol, 210, pp. 331-338; 
Muir, E.M., Fyfe, I., Gardiner, S., Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells (2010) J Biotechnol, 145, pp. 103-110; 
Barnabe-Heider, F., Frisen, J., Stem cells for spinal cord repair (2008) Cell Stem Cell, 3, pp. 16-24; 
Bradbury, E.J., McMahon, S.B., Spinal cord repair strategies: why do they work? (2006) Nat Rev Neurosci, 7, pp. 644-653; 
Xu, X.M., Onifer, S.M., Transplantation-mediated strategies to promote axonal regeneration following spinal cord injury (2009) Respir Physiol Neurobiol, 169, pp. 171-182; 
Sykova, E., Homola, A., Mazanec, R., Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury (2006) Cell Transplant, 15, pp. 675-687; 
Wright, K.T., Masri, W.E., Osman, A., Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications (2011) Stem Cells, 29, pp. 169-178; 
Cizkova, D., Kakinohana, O., Kucharova, K., Functional recovery in rats with ischemic paraplegia after spinal grafting of human spinal stem cells (2007) Neuroscience, 147, pp. 546-560; 
Hofstetter, C.P., Schwarz, E.J., Hess, D., Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery (2002) Proc Natl Acad Sci USA, 99, pp. 2199-2204; 
Cizkova, D., Nagyova, M., Slovinska, L., Response of ependymal progenitors to spinal cord injury or enhanced physical activity in adult rat (2009) Cell Mol Neurobiol, 29, pp. 999-1013; 
Barnabe-Heider, F., Goritz, C., Sabelstrom, H., Origin of new glial cells in intact and injured adult spinal cord (2010) Cell Stem Cell, 7, pp. 470-482; 
Sykova, E., Jendelova, P., Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord (2005) Ann N Y Acad Sci, pp. 146-160; 
Kubinova, S., Sykova, E., Nanotechnology for treatment of stroke and spinal cord injury (2010) Nanomedicine-UK, 5, pp. 99-108; 
Madigan, N.N., McMahon, S., O{\textquoteright}Brien, T., Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds (2009) Respir Physiol Neurobiol, 169, pp. 183-199; 
Blits, B., Boer, G.J., Verhaagen, J., Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration (2002) Cell Transplant, 11, pp. 593-613; 
Tetzlaff, W., Okon, E.B., Karimi-Abdolrezaee, S., A systematic review of cellular transplantation therapies for spinal cord injury (2011) J Neurotrauma, 28, pp. 1611-1682; 
Sykova, E., Jendelova, P., Urdzikova, L., Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair (2006) Cell Mol Neurobiol, 26, pp. 1113-1129; 
Papastefanaki, F., Chen, J., Lavdas, A.A., Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury (2007) Brain, 130, pp. 2159-2174; 
Raisman, G., Repair of spinal cord injury by transplantation of olfactory ensheathing cells (2007) C R Biol, 330, pp. 557-560; 
Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors (2006) Cell, 126, pp. 663-676; 
Okita, K., Ichisaka, T., Yamanaka, S., Generation of germline-competent induced pluripotent stem cells (2007) Nature, 448, pp. 313-317; 
Zhao, T., Zhang, Z.N., Rong, Z., Immunogenicity of induced pluripotent stem cells (2011) Nature, 474, pp. 212-215; 
Thomson, J.A., Odorico, J.S., Human embryonic stem cell and embryonic germ cell lines (2000) Trends Biotechnol, 18, pp. 53-57; 
Zeng, X., Rao, M.S., Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement (2007) Neuroscience, 145, pp. 1348-1358; 
Holubcova, Z., Matula, P., Sedlackova, M., Human embryonic stem cells suffer from centrosomal amplification (2011) Stem Cells, 29, pp. 46-56; 
Liu, S., Qu, Y., Stewart, T.J., Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation (2000) Proc Natl Acad Sci USA, 97, pp. 6126-6131; 
Kakinohana, O., Cizkova, D., Tomori, Z., Region-specific cell grafting into cervical and lumbar spinal cord in rat: a qualitative and quantitative stereological study (2004) Exp Neurol, 190, pp. 122-132; 
Lang, K.J., Rathjen, J., Vassilieva, S., Differentiation of embryonic stem cells to a neural fate: a route to re-building the nervous system? (2004) J Neurosci Res, 76, pp. 184-192; 
Carpenter, M.K., Inokuma, M.S., Denham, J., Enrichment of neurons and neural precursors from human embryonic stem cells (2001) Exp Neurol, 172, pp. 383-397; 
Li, X.J., Du, Z.W., Zarnowska, E.D., Specification of motoneurons from human embryonic stem cells (2005) Nat Biotechnol, 23, pp. 215-221; 
Keirstead, H.S., Nistor, G., Bernal, G., Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury (2005) J Neurosci, 25, pp. 4694-4705; 
Seminatore, C., Polentes, J., Ellman, D., The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors (2010) Stroke, 41, pp. 153-159; 
Faulkner, J., Keirstead, H.S., Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury (2005) Transpl Immunol, 15, pp. 131-142; 
Nistor, G.I., Totoiu, M.O., Haque, N., Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation (2005) Glia, 49, pp. 385-396; 
Cloutier, F., Siegenthaler, M.M., Nistor, G., Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm (2006) Regen Med, 1, pp. 469-479; 
Altman, J., Are new neurons formed in the brains of adult mammals? (1962) Science, 135, pp. 1127-1128; 
Gage, F.H., Mammalian neural stem cells (2000) Science, 287, pp. 1433-1438; 
Goldman, S., Stem and progenitor cell-based therapy of the human central nervous system (2005) Nat Biotechnol, 23, pp. 862-871; 
Horky, L.L., Galimi, F., Gage, F.H., Fate of endogenous stem/progenitor cells following spinal cord injury (2006) J Comp Neurol, 498, pp. 525-538; 
Setoguchi, T., Nakashima, K., Takizawa, T., Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor (2004) Exp Neurol, 189, pp. 33-44; 
Cizkova, D., Cizek, M., Nagyova, M., Enrichment of rat oligodendrocyte progenitor cells by magnetic cell sorting (2009) J Neurosci Meth, 184, pp. 88-94; 
Lu, P., Jones, L.L., Snyder, E.Y., Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury (2003) Exp Neurol, 181, pp. 115-129; 
Ishii, K., Nakamura, M., Dai, H., Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury (2006) J Neurosci Res, 84, pp. 1669-1681; 
Tarasenko, Y.I., Gao, J., Nie, L., Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior (2007) J Neurosci Res, 85, pp. 47-57; 
Cummings, B.J., Uchida, N., Tamaki, S.J., Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice (2005) Proc Natl Acad Sci USA, 102, pp. 14069-14074; 
Marsala, M., Kakinohana, O., Yaksh, T.L., Spinal implantation of hNT neurons and neuronal precursors: graft survival and functional effects in rats with ischemic spastic paraplegia (2004) Eur J Neurosci, 20, pp. 2401-2414; 
Wu, R., Wang, H., Xia, X., Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS (2009) Antioxid Redox Signal, 11, pp. 1523-1534; 
Romanyuk, N., Amemori, T., Turnovcova, K., (2011), Using human fetal neural stem cells or human induced pluripotent stem cell-derived neural precursors for the treatment of experimental spinal cord injury. 8th IBRO World Congress of Neuroscience. Florence, ItalyHooshmand, M.J., Sontag, C.J., Uchida, N., Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery (2009) PLoS ONE, 4, pp. e5871; 
Hofstetter, C.P., Holmstrom, N.A., Lilja, J.A., Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome (2005) Nature Neurosci, 8, pp. 346-353; 
Mukhida, K., Mendez, I., McLeod, M., Spinal GABAergic transplants attenuate mechanical allodynia in a rat model of neuropathic pain (2007) Stem Cells, 25, pp. 2874-2885; 
Takami, T., Oudega, M., Bates, M.L., Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord (2002) J Neurosci, 22, pp. 6670-6681; 
Pinzon, A., Calancie, B., Oudega, M., Conduction of impulses by axons regenerated in a Schwann cell graft in the transected adult rat thoracic spinal cord (2001) J Neurosci Res, 64, pp. 533-541; 
Guest, J.D., Hiester, E.D., Bunge, R.P., Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury (2005) Exp Neurol, 192, pp. 384-393; 
Pearse, D.D., Sanchez, A.R., Pereira, F.C., Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery (2007) Glia, 55, pp. 976-1000; 
Bunge, M.B., Novel combination strategies to repair the injured mammalian spinal cord (2008) J Spinal Cord Med, 31, pp. 262-269; 
Lu, P., Tuszynski, M.H., Growth factors and combinatorial therapies for CNS regeneration (2008) Exp Neurol, 209, pp. 313-320; 
Afshari, F.T., Kwok, J.C., Fawcett, J.W., Astrocyte-produced ephrins inhibit schwann cell migration via VAV2 signaling (2010) J Neurosci, 30, pp. 4246-4255; 
Mackay-Sim, A., Olfactory ensheathing cells and spinal cord repair (2005) Keio J Med, 54, pp. 8-14; 
Feron, F., Perry, C., Cochrane, J., Autologous olfactory ensheathing cell transplantation in human spinal cord injury (2005) Brain, 128, pp. 2951-2960; 
Lima, C., Pratas-Vital, J., Escada, P., Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study (2006) J Spinal Cord Med, 29, pp. 191-203; 
Mackay-Sim, A., Feron, F., Cochrane, J., Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial (2008) Brain, 131, pp. 2376-2386; 
Fouad, K., Schnell, L., Bunge, M.B., Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord (2005) J Neurosci, 25, pp. 1169-1178; 
Amemori, T., Jendelova, P., Ruzickova, K., Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat (2010) Cytotherapy, 12, pp. 212-225; 
Salem, H.K., Thiemermann, C., Mesenchymal stromal cells: current understanding and clinical status (2010) Stem Cells, 28, pp. 585-596; 
Cizkova, D., Rosocha, J., Vanicky, I., Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat (2006) Cell Mol Neurobiol, 26, pp. 1167-1180; 
Sykova, E., Jendelova, P., Migration, fate and in vivo imaging of adult stem cells in the CNS (2007) Cell Death Differ, 14, pp. 1336-1342; 
Urdzikova, L., Jendelova, P., Glogarova, K., Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats (2006) J Neurotrauma, 23, pp. 1379-1391; 
Peran, M., Marchal, J.A., Rodriguez-Serrano, F., Transdifferentiation: why and how? (2011) Cell Biol Int, 35, pp. 373-379; 
Lambert, A.P.F., Zandonai, A.F., Bonatto, D., Differentiation of human adipose-derived adult stem cells into neuronal tissue: Does it work? (2009) Differentiation, 77, pp. 221-228; 
Uccelli, A., Benvenuto, F., Laroni, A., Neuroprotective features of mesenchymal stem cells (2011) Best Pract Res Cl Ha, 24, pp. 59-64; 
Geffner, L.F., Santacruz, P., Izurieta, M., Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies (2008) Cell Transplant, 17, pp. 1277-1293; 
Park, H.C., Shim, Y.S., Ha, Y., Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor (2005) Tissue Eng, 11, pp. 913-922; 
Yoon, S.H., Shim, Y.S., Park, Y.H., Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial (2007) Stem Cells, 25, pp. 2066-2073; 
Callera, F., do Nascimento, R.X., Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study (2006) Exp Hematol, 34, pp. 130-131; 
Deda, H., Inci, M.C., Kurekci, A.E., Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up (2008) Cytotherapy, 10, pp. 565-574; 
Saito, F., Nakatani, T., Iwase, M., Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report (2008) J Trauma, 64, pp. 53-59; 
Pal, R., Venkataramana, N.K., Bansal, A., Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study (2009) Cytotherapy, 11, pp. 897-911; 
Mason, M.R., Ehlert, E.M., Eggers, R., Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons (2010) Mol Ther, 18, pp. 715-724; 
Petruska, J.C., Kitay, B., Boyce, V.S., Intramuscular AAV delivery of NT-3 alters synaptic transmission to motoneurons in adult rats (2010) Eur J Neurosci, 32, pp. 997-1005; 
Tuszynski, M.H., Nerve growth factor gene delivery: animal models to clinical trials (2007) Dev Neurobiol, 67, pp. 1204-1215; 
Blits, B., Derks, S., Twisk, J., Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors (2010) J Neurosci Meth, 185, pp. 257-263; 
Aalbers, C.J., Tak, P.P., Vervoordeldonk, M.J., Advancements in adeno-associated viral gene therapy approaches: exploring a new horizon (2011) F1000 Med Reports, 3, p. 17; 
Straley, K.S., Foo, C.W.P., Heilshorn, S.C., Biomaterial design strategies for the treatment of spinal cord injuries (2010) J Neurotrauma, 27, pp. 1-19; 
Hejcl, A., Lesny, P., Pradny, M., Biocompatible hydrogels in spinal cord injury repair (2008) Physiol Res, 57, pp. S121-S132; 
Friedman, J.A., Windebank, A.J., Moore, M.J., Biodegradable polymer grafts for surgical repair of the injured spinal cord (2002) Neurosurgery, 51, pp. 742-752; 
De Laporte, L., Lei Yan, A., Shea, L.D., Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury (2009) Biomaterials, 30, pp. 2361-2368; 
Wong, D.Y., Leveque, J.C., Brumblay, H., Macro-architectures in spinal cord scaffold implants influence regeneration (2008) J Neurotrauma, 25, pp. 1027-1037; 
P{\^e}go, A.P., Poot, A.A., Grijpma, D.W., Copolymers of trimethylene carbonate and epsilon-caprolactone for porous nerve guides: Synthesis and properties (2001) J Biomat Sci-Polym E, 12, pp. 35-53; 
Tsai, E.C., Dalton, P.D., Shoichet, M.S., Synthetic hydrogel guidance channels facilitate regeneration of adult rat brainstem motor axons after complete spinal cord transection (2004) J Neurotrauma, 21, pp. 789-804; 
Woerly, S., Fort, S., Pignot-Paintrand, I., Development of a sialic acid-containing hydrogel of poly[N-(2-hydroxypropyl) methacrylamide]: characterization and implantation study (2008) Biomacromolecules, 9, pp. 2329-2337; 
Collazos-Castro, J.E., Polo, J.L., Hernandez-Labrado, G.R., Bioelectrochemical control of neural cell development on conducting polymers (2010) Biomaterials, 31, pp. 9244-9255; 
Ciardelli, G., Chiono, V., Materials for peripheral nerve regeneration (2006) Macromol Biosci, 6, pp. 13-26; 
Yoshii, S., Ito, S., Shima, M., Functional restoration of rabbit spinal cord using collagen-filament scaffold (2009) J Tissue Eng Regen M, 3, pp. 19-25; 
Taylor, S.J., McDonald III, J.W., Sakiyama-Elbert, S.E., Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury (2004) J Control Release, 98, pp. 281-294; 
P{\^e}go, A.P., Mar, F.M., Rocha, D.N., Scaffold-driven regenerative therapy for the spinal cord injury - biomimeting neurogenesis in the CNS (2011) Histol Histopathol, 26, p. 289; 
Wei, Y.T., He, Y., Xu, C.L., Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-L-lysine to promote axon regrowth after spinal cord injury (2010) J Biomed Mater Res B, 95, pp. 110-117; 
Park, J., Lim, E., Back, S., Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor (2010) J Biomed Mater Res A, 93, pp. 1091-1099; 
Gros, T., Sakamoto, J.S., Blesch, A., Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds (2010) Biomaterials, 31, pp. 6719-6729; 
Prang, P., Muller, R., Eljaouhari, A., The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels (2006) Biomaterials, 27, pp. 3560-3569; 
Bozkurt, G., Mothe, A.J., Zahir, T., Chitosan channels containing spinal cord-derived stem/progenitor cells for repair of subacute spinal cord injury in the rat (2010) Neurosurgery, 67, pp. 1733-1744; 
Shen, Y., Qian, Y., Zhang, H., Guidance of olfactory ensheathing cell growth and migration on electrospun silk fibroin scaffolds (2010) Cell Transplant, 19, pp. 147-157; 
Novikova, L.N., Pettersson, J., Brohlin, M., Biodegradable poly-beta-hydroxybutyrate scaffold seeded with Schwann cells to promote spinal cord repair (2008) Biomaterials, 29, pp. 1198-1206; 
Bhattarai, N., Li, Z., Gunn, J., Natural-synthetic polyblend nanofibers for biomedical applications (2009) Adv Mater, 21, pp. 2792-2797; 
Hejcl, A., Lesny, P., Pradny, M., Macroporous hydrogels based on 2-hydroxyethyl methacrylate. Part 6: 3D hydrogels with positive and negative surface charges and polyelectrolyte complexes in spinal cord injury repair (2009) J Mater Sci Mater Med, 20, pp. 1571-1577; 
Kubinova, S., Horak, D., Sykova, E., Cholesterol-modified superporous poly(2-hydroxyethyl methacrylate) scaffolds for tissue engineering (2009) Biomaterials, 30, pp. 4601-4609; 
Kubinova, S., Horak, D., Hejcl, A., Highly superporous cholesterol-modified poly(2-hydroxyethyl methacrylate) scaffolds for spinal cord injury repair (2011) J Biomed Mater Res A, 99, pp. 618-629; 
Gunn, J.W., Turner, S.D., Mann, B.K., Adhesive and mechanical properties of hydrogels influence neurite extension (2005) J Biomed Mater Res A, 72, pp. 91-97; 
Kubinova, S., Horak, D., Kozubenko, N., The use of superporous Ac-CGGASIKVAVS-OH-modified PHEMA scaffolds to promote cell adhesion and the differentiation of human fetal neural precursors (2010) Biomaterials, 31, pp. 5966-5975; 
Cui, H., Webber, M.J., Stupp, S.I., Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials (2010) Biopolymers, 94, pp. 1-18; 
Tysseling-Mattiace, V.M., Sahni, V., Niece, K.L., Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury (2008) J Neurosci, 28, pp. 3814-3823; 
Bellamkonda, R., Ranieri, J.P., Bouche, N., Hydrogel-based three-dimensional matrix for neural cells (1995) J Biomed Mater Res, 29, pp. 663-671; 
Wang, M., Zhai, P., Chen, X., Bioengineered scaffolds for spinal cord repair (2011) Tissue Eng Pt B-Rev, 17, pp. 177-194; 
Stokols, S., Sakamoto, J., Breckon, C., Templated agarose scaffolds support linear axonal regeneration (2006) Tissue Eng, 12, pp. 2777-2787; 
Stokols, S., Tuszynski, M.H., Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury (2006) Biomaterials, 27, pp. 443-451; 
Moore, M.J., Friedman, J.A., Lewellyn, E.B., Multiple-channel scaffolds to promote spinal cord axon regeneration (2006) Biomaterials, 27, pp. 419-429; 
Wang, H.B., Mullins, M.E., Cregg, J.M., Creation of highly aligned electrospun poly-L-lactic acid fibers for nerve regeneration applications (2009) J Neural Eng, 6, p. 016001; 
Wang, H.B., Mullins, M.E., Cregg, J.M., Varying the diameter of aligned electrospun fibers alters neurite outgrowth and Schwann cell migration (2010) Acta Biomater, 6, pp. 2970-2978; 
Xie, J., MacEwan, M.R., Li, X., Neurite outgrowth on nanofiber scaffolds with different orders, structures, and surface properties (2009) ACS Nano, 3, pp. 1151-1159; 
Hurtado, A., Cregg, J.M., Wang, H.B., Robust CNS regeneration after complete spinal cord transection using aligned poly-l-lactic acid microfibers (2011) Biomaterials, 32, pp. 6068-6079; 
Guo, J., Su, H., Zeng, Y., Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold (2007) Nanomedicine, 3, pp. 311-321; 
Johnson, P.J., Tatara, A., McCreedy, D.A., Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI (2010) Soft Matter, 6, pp. 5127-5137; 
Olson, H.E., Rooney, G.E., Gross, L., Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord (2009) Tissue Eng Pt A, 15, pp. 1797-1805; 
Hurtado, A., Moon, L.D., Maquet, V., Poly (D, L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord (2006) Biomaterials, 27, pp. 430-442; 
Woerly, S., Pinet, E., de Robertis, L., Spinal cord repair with PHPMA hydrogel containing RGD peptides (NeuroGel) (2001) Biomaterials, 22, pp. 1095-1111; 
Loh, N.K., Woerly, S., Bunt, S.M., The regrowth of axons within tissue defects in the CNS is promoted by implanted hydrogel matrices that contain BDNF and CNTF producing fibroblasts (2001) Exp Neurol, 170, pp. 72-84; 
Hejcl, A., Sedy, J., Kapcalova, M., HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury (2010) Stem Cells Dev, 19, pp. 1535-1546; 
Willerth, S.M., Sakiyama-Elbert, S.E., Approaches to neural tissue engineering using scaffolds for drug delivery (2007) Adv Drug Deliv Rev, 59, pp. 325-338; 
Jimenez Hamann, M.C., Tator, C.H., Shoichet, M.S., Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord (2005) Exp Neurol, 194, pp. 106-119; 
Jain, A., Kim, Y.T., McKeon, R.J., In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury (2006) Biomaterials, 27, pp. 497-504; 
Piantino, J., Burdick, J.A., Goldberg, D., An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury (2006) Exp Neurol, 201, pp. 359-367; 
Hendriks, W.T., Ruitenberg, M.J., Blits, B., Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord (2004) Prog Brain Res, 146, pp. 451-476; 
Abdellatif, A.A., Pelt, J.L., Benton, R.L., Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems (2006) J Neurosci Res, 84, pp. 553-567; 
Blits, B., Bunge, M.B., Direct gene therapy for repair of the spinal cord (2006) J Neurotrauma, 23, pp. 508-520; 
Oliveira, H., Fernandez, R., Pires, L.R., Targeted gene delivery into peripheral sensorial neurons mediated by self-assembled vectors composed of poly(ethylene imine) and tetanus toxin fragment c (2010) J Control Release, 143, pp. 350-358; 
Oliveira, H., Pires, L.R., Fernandez, R., Chitosan-based gene delivery vectors targeted to the peripheral nervous system (2010) J Biomed Mater Res A, 95, pp. 801-810; 
Whitehead, K.A., Langer, R., Anderson, D.G., Knocking down barriers: advances in siRNA delivery (2009) Nat Rev Drug Discov, 8, pp. 129-138; 
Mittnacht, U., Hartmann, H., Hein, S., Chitosan/siRNA nanoparticles biofunctionalize nerve implants and enable neurite outgrowth (2010) Nano Lett, 10, pp. 3933-3939; 
Richardson, P.M., McGuinness, U.M., Aguayo, A.J., Axons from CNS neurons regenerate into PNS grafts (1980) Nature, 284, pp. 264-265; 
David, S., Aguayo, A.J., Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats (1981) Science, 214, pp. 931-933; 
Schweigreiter, R., The natural history of the myelin-derived nerve growth inhibitor Nogo-A (2008) Neuron Glia Biol, 4, pp. 83-89; 
Vargas, M.E., Barres, B.A., Why is Wallerian degeneration in the CNS so slow? (2007) Annu Rev Neurosci, 30, pp. 153-179; 
Neumann, S., Woolf, C.J., Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury (1999) Neuron, 23, pp. 83-91; 
Ylera, B., Erturk, A., Hellal, F., Chronically CNS-injured adult sensory neurons gain regenerative competence upon a lesion of their peripheral axon (2009) Curr Biol, 19, pp. 930-936; 
Qiu, J., Cai, D., Dai, H., Spinal axon regeneration induced by elevation of cyclic AMP (2002) Neuron, 34, pp. 895-903; 
Jacob, J.M., Croes, S.A., Acceleration of axonal outgrowth in motor axons from mature and old F344 rats after a conditioning lesion (1998) Exp Neurol, 152, pp. 231-237; 
McQuarrie, I.G., Grafstein, B., Effect of a conditioning lesion on optic nerve regeneration in goldfish (1981) Brain Res, 216, pp. 253-264; 
Neumann, S., Bradke, F., Tessier-Lavigne, M., Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation (2002) Neuron, 34, pp. 885-893; 
Zou, H., Ho, C., Wong, K., Axotomy-induced Smad1 activation promotes axonal growth in adult sensory neurons (2009) J Neurosci, 29, pp. 7116-7123; 
Seijffers, R., Mills, C.D., Woolf, C.J., ATF3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration (2007) J Neurosci, 27, pp. 7911-7920; 
Cafferty, W.B., Gardiner, N.J., Gavazzi, I., Leukemia inhibitory factor determines the growth status of injured adult sensory neurons (2001) J Neurosci, 21, pp. 7161-7170; 
Cafferty, W.B., Gardiner, N.J., Das, P., Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice (2004) J Neurosci, 24, pp. 4432-4443; 
Cao, Z., Gao, Y., Bryson, J.B., The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth (2006) J Neurosci, 26, pp. 5565-5573; 
Minor, K., Phillips, J., Seeds, N.W., Tissue plasminogen activator promotes axonal outgrowth on CNS myelin after conditioned injury (2009) J Neurochem, 109, pp. 706-715; 
Pearse, D.D., Pereira, F.C., Marcillo, A.E., cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury (2004) Nat Med, 10, pp. 610-616; 
Nikulina, E., Tidwell, J.L., Dai, H.N., The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery (2004) Proc Natl Acad Sci USA, 101, pp. 8786-8790; 
Cai, D., Deng, K., Mellado, W., Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro (2002) Neuron, 35, pp. 711-719; 
Ma, T.C., Campana, A., Lange, P.S., A large-scale chemical screen for regulators of the arginase 1 promoter identifies the soy isoflavone daidzeinas a clinically approved small molecule that can promote neuronal protection or regeneration via a cAMP-independent pathway (2010) J Neurosci, 30, pp. 739-748; 
Bregman, B.S., Kunkel-Bagden, E., Schnell, L., Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors (1995) Nature, 378, pp. 498-501; 
Bradbury, E.J., Moon, L.D., Popat, R.J., Chondroitinase ABC promotes functional recovery after spinal cord injury (2002) Nature, 416, pp. 636-640; 
Bareyre, F.M., Kerschensteiner, M., Raineteau, O., The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats (2004) Nature Neurosci, 7, pp. 269-277; 
Saberi, H., Firouzi, M., Habibi, Z., Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases (2011) J Neurosurg Spine, 15, pp. 515-525; 
Fukushima, K., Enomoto, M., Tomizawa, S., The axonal regeneration across a honeycomb collagen sponge applied to the transected spinal cord (2008) J Med Dent Sci, 55, pp. 71-79; 
Madaghiele, M., Sannino, A., Yannas, I.V., Collagen-based matrices with axially oriented pores (2008) J Biomed Mater Res A, 85, pp. 757-767; 
Liang, W., Han, Q., Jin, W., The promotion of neurological recovery in the rat spinal cord crushed injury model by collagen-binding BDNF (2010) Biomaterials, 31, pp. 8634-8641; 
Liu, T., Houle, J.D., Xu, J., Nanofibrous Collagen Nerve Conduits for Spinal Cord Repair (2012) Tissue Eng Pt A, 18, pp. 1057-1066; 
Khaing, Z.Z., Milman, B.D., Vanscoy, J.E., High molecular weight hyaluronic acid limits astrocyte activation and scar formation after spinal cord injury (2011) J Neural Eng, 8, p. 046033; 
Mehrotra, S., Lynam, D., Maloney, R., Time Controlled Protein Release from Layer-by-Layer Assembled Multilayer Functionalized Agarose Hydrogels (2010) Adv Funct Mater, 20, pp. 247-258; 
Kataoka, K., Suzuki, Y., Kitada, M., Alginate enhances elongation of early regenerating axons in spinal cord of young rats (2004) Tissue Eng, 10, pp. 493-504; 
Chen, X., Yang, Y., Yao, J., Bone marrow stromal cells-loaded chitosan conduits promote repair of complete transection injury in rat spinal cord (2011) J Mater Sci Mater Med, 22, pp. 2347-2356; 
Kim, H., Tator, C.H., Shoichet, M.S., Chitosan implants in the rat spinal cord: biocompatibility and biodegradation (2011) J Biomed Mater Res A, 97, pp. 395-404; 
Ding, C., Guo, X., Cheng, B., Fabrication and radial compressive properties of the biodegradable woven regeneration conduits for peripheral nerve repair (2011) Adv Mat Res, 332-334, pp. 1481-1484; 
Suwantong, O., Waleetorncheepsawat, S., Sanchavanakit, N., In vitro biocompatibility of electrospun poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) fiber mats (2007) Int J Biol Macromol, 40, pp. 217-223; 
Pritchard, C.D., Slotkin, J.R., Yu, D., Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stem cells (2010) J Neurosci Meth, 188, pp. 258-269; 
Pires, L.R., Guarino, V., Barrias, C.C., Tunning poly(trymethylene carbonate-co-epsilon-caprolactone) fibers for nerve regeneration (2011) Histol Histopathol, 26, pp. 251-252; 
Tysseling, V.M., Sahni, V., Pashuck, E.T., Self-assembling peptide amphiphile promotes plasticity of serotonergic fibers following spinal cord injury (2010) J Neurosci Res, 88, pp. 3161-3170
},
	month = {2012///},
	pages = {2564 - 2582},
	abstract = {Spinal cord injury triggers a complex set of events that lead to tissue healing without the restoration of normal function due to the poor regenerative capacity of the spinal cord. Nevertheless, current knowledge about the intrinsic regenerative ability of central nervous system axons, when in a supportive environment, has made the prospect of treating spinal cord injury a reality. Among the range of strategies under investigation, cell-based therapies offer the most promising results, due to the multifactorial roles that these cells can fulfil. However, the best cell source is still a matter of debate, as are clinical issues that include the optimal cell dose as well as the timing and route of administration. In this context, the role of biomaterials is gaining importance. These can not only act as vehicles for the administered cells but also, in the case of chronic lesions, can be used to fill the permanent cyst, thus creating a more favourable and conducive environment for axonal regeneration in addition to serving as local delivery systems of therapeutic agents to improve the regenerative milieu. Some of the candidate molecules for the future are discussed in view of the knowledge derived from studying the mechanisms that facilitate the intrinsic regenerative capacity of central nervous system neurons. The future challenge for the multidisciplinary teams working in the field is to translate the knowledge acquired in basic research into effective combinatorial therapies to be applied in the clinic. {\textcopyright} 2012 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.},
	keywords = {Biomaterials, Cell therapies, Clinical trials, Conditioning lesion, Gene therapy, Growth factors, Spinal cord injury, Stem cells},
	isbn = {15821838 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84868098934\&partnerID=40\&md5=adb61a7d32054dc21aa4d733bc31427f},
	author = {P{\^e}go, A.P. and Kubinova, S. and Cizkova, D. and Vanicky, I. and Mar, F.M. and Sousa, M.M. and Sykova, E.}
}
